The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials Histone 3 (H3) K27M–mutant diffuse ...

Balluff 18 series diffuse sensors detect objects based on their surface, color and material. The transmitter and receiver are housed together in a single unit so that users can easily mount the ...

In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492), polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) showed a significant progression-free ...

To run a successful business, we bring together a diverse group of people with different skill sets to cover all areas of the business. This results in people who might have very different values and ...

Apple will partner with Samsung to produce next-generation image sensor chips for upcoming iPhone models at a facility in Texas, marking a major departure from its exclusive reliance on Sony, ...

What Is Modeyso, and Why Does It Matter? Modeyso (dordaviprone) is a new oral medicine that treats a rare and aggressive brain tumor, called diffuse midline glioma (DMG), that has a tumor mutation ...

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Hypofractionated radiation therapy with concurrent and adjuvant temozolomide is conditionally recommended for elderly patients. HealthDay News — In a clinical practice guideline issued by the American ...